Altana Pharma Coveters Wary About A Patent (New Ratings)

Altana Pharma Coveters Wary About A Patent (New Ratings)
0824 GMT [Dow Jones] Merck Finck says investors interested in acquiring Altana’s (AAA) pharmaceuticals division seem to be concerned about risks arising from expiration of the patent on Pantoprazole.